In view of VEGF playing role in angiogenesis-related diseases, e.g., macular degeneration, psoriasis and tumour proliferation, the aforementioned natural compounds that attenuated VEGF-induced angiogenesis could be promising regarding the development of relevant drugs for angiogenesis-related disease treatment. This evidence concerns the gene VEGFA and neoplasm.